Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 909 clinical trials
featured
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma

Gene transfer is a new cancer therapy takes white blood cells from a person and grows them in a lab. The cells are changed with a virus to attack tumor cells, then returned to the person

carcinoma
clear cell renal cell carcinoma
clear cell carcinoma
renal cell cancer
primary cancer
  • 144 views
  • 22 Dec, 2020
  • 1 location
featured
TRANSFORM – B cell non-Hodgkin lymphoma - JCAR017-BCM-003 - US  

The study will be conducted in compliance with the International Council for Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Practice (GCP) and applicable regulatory requirements.   This is a randomized, open-label, parallel-group, multi-center trial in adult subjects with Relapsed or refractory (R/R) aggressive Non-Hodgkin …

  • 2946 views
  • 05 Jan, 2021
  • 10 locations
featured
Receptor 2 negative (HR+/HER2-) breast cancer – Astra Zeneca

People with breast cancer are asked to participate in a research study being conducted by Monter Cancer Center.

  • 0 views
  • 22 Jul, 2020
  • 1 location
featured
PROSTATE CANCER RESEARCH STUDY

PROSTATE CANCER RESEARCH STUDY

  • 76 views
  • 08 Nov, 2020
  • 1 location
featured
A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

  • 314 views
  • 23 Nov, 2020
  • 4 locations
featured
PILOT - B cell non-Hodgkin lymphoma - TRANSCEND-PILOT-017006 - US  

This is a Phase 2, open-label, multicenter study to determine the efficacy and safety of lisocabtagene maraleucel (JCAR017) in adult subjects who have relapsed from, or are refractory to, a single line of immunochemotherapy for aggressive B-cell non-Hodgkin lymphoma (NHL) and are ineligible for hematopoietic stem cell transplant (based on …

  • 2758 views
  • 15 Dec, 2020
  • 12 locations
featured
Cancer: Do You Have Cancer and Problems With Constipation?

Cancer: Do You Have Cancer and Problems With Constipation?

  • 60 views
  • 08 Nov, 2020
  • 1 location
featured
CALGB 80802: A Phase III Randomized Study of Sorafenib plus Doxorubicin Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC).

CALGB 80802: A Phase III Randomized Study of Sorafenib plus Doxorubicin Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC).

  • 84 views
  • 08 Nov, 2020
  • 1 location
featured
Alliance A021202: Prospective Randomized Phase II Trial of Pazopanib (NSC # 737754, IND 75648) Versus Placebo in Patients With Progressive Carcinoid Tumors

Alliance A021202: Prospective Randomized Phase II Trial of Pazopanib (NSC # 737754, IND 75648) Versus Placebo in Patients With Progressive Carcinoid Tumors

  • 90 views
  • 08 Nov, 2020
  • 1 location
featured
An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

cancer chemotherapy
systemic therapy
cancer
lung cancer
KIT
  • 358 views
  • 08 Dec, 2020
  • 4 locations